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Abstract
Background: Medical screening detects risk factors for disease or presence of disease in otherwise well persons in
order to intervene early and reduce morbidity and mortality. During antenatal care (ANC) it is important to detect
conditions that complicate pregnancy, like gestational diabetes mellitus (GDM). Despite international and local
guidelines recommending screening for GDM during ANC, there is evidence to suggest that the practice was not
being carried out adequately. A major challenge may be lack of consensus on uniform GDM screening and
diagnostic guidelines internationally and locally.
The primary objective was to determine the magnitude of screening for GDM among women receiving ANC at the
Aga Khan Hospital, Dar es Salaam and Muhimbili National Hospital, Dar es Salaam. Secondary objectives were: to
determine the methods used by health practitioners to screen for GDM, to determine the magnitude of
undiagnosed gestational diabetes mellitus among women attending ANC and factors associated with screening for
GDM among these women.
Methods: A cross-sectional analytical study was done. Data collection was done using pre-tested questionnaires
and reviewing antenatal care records. The proportion of women attending ANC who were screened for GDM was
determined. The 75 g Oral Glucose Tolerance Test (OGTT) was offered to women who had not been screened after
education and consent.
Results: Only 107 out of 358 (29.9%) had been offered some form of GDM screening. Tests used for GDM
screening were random blood sugar (56.8%), fasting blood sugar (32.8%), HbA1C (6%) and 75 g OGTT (3.4%). The
uptake of the OGTT was 27%. Of these women the prevalence of GDM was 27.9%. Factors associated with
screening for GDM were history of big baby, history of pregnancy induced hypertension and participant awareness
of GDM (all p: < 0.05).
Conclusions: Screening for GDM among women attending ANC was lower than the World Health Organization
target. Efforts should be directed towards promoting GDM screening, increasing awareness about GDM and
developing more effective screening methods.
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Background
Medical screening identifies apparently healthy people
who have a disease or increased risk of disease [1]. The
strategy helps clinicians to detect unrecognized symptom-
atic and pre-symptomatic disease. Screening for condi-
tions therefore enables early diagnosis and intervention
which improves clinical outcomes and reduces costs of
health care.
Gestational diabetes mellitus (GDM) is diabetes that is
first diagnosed in the second or third trimester of preg-
nancy that is not clearly either preexisting type 1 or type
2 diabetes [2]. GDM is one of the conditions which
should be screened for during antenatal care (ANC).
This is because GDM increases risk of maternal and fetal
complications during pregnancy [3] and adverse health
outcomes in the future [4].
The prevalence of GDM varies across populations, ran-
ging from 10.4 to 25% across the world [5]. Over 90% of
cases occur in low and middle income countries [6]. Al-
though there is a lot of literature on the prevalence, man-
agement and complications of GDM, little focus has been
put on how much GDM screening i.e. the magnitude of
GDM screening is actually done. A study done in Uganda,
Tanzania and Burkina Faso showed that health care
workers did not provide all required services during ANC
despite good attendance [7]. It is worth also noting that
guidelines for screening for GDM vary across the globe and
within countries [8]. In Tanzania the national guidelines [9]
vary from the Tanzania diabetic association [10] guidelines
and both vary from the World Health Organization
(WHO) guidelines [3]. Tests used to screen for GDM in
these national guidelines include the oral glucose tolerance
test (OGTT), random blood sugar (RBS), fasting blood
sugar (FBS) and glycated haemoglobin (HbA1C).
Lack of vigilance to screen for GDM and varying
guidelines may be responsible for poor GDM screening
practices in low resource settings as shown in Cameroon
[11]. From other studies, some factors associated with
screening for GDM include: education status/ literacy,
husband support, family support, awareness of GDM or
its risks, health care providers informing the women
about the test and help with household work [12], mari-
tal status, women’s autonomy [13], employment status
[14], private health insurance status, distance to hospital,
journey time to health facility, mode of transport and
ability to pay for the service/ financial status [15].
Given the significance of the unfavourable pregnancy
outcomes of GDM but paucity of data on how much
screening is done for the condition, this study sought to
determine the magnitude of screening for GDM among
women attending ANC at two tertiary hospitals. The
study also determined the tests used for GDM screening
during antenatal care, prevalence of undiagnosed GDM
and factors associated with screening for GDM.
Methods
Design and study site
A cross-sectional analytic study was done at the Aga
Khan Hospital Dar es Salaam and Muhimbili National
Hospital, Dar es Salaam in Tanzania. The Aga Khan
Hospital is a not for profit, tertiary care facility and the
biggest private hospital in Tanzania. Its antenatal care
clinic attends to averagely 300 women a week. Muhim-
bili hospital is the national referral hospital providing
tertiary care services to referral cases and the population
surrounding it. Antenatal care attendance in this hos-
pital averages 1000 women per week.
Participants
Total sample size was 358. Sample size was determined
using a standard formula on the basis of 22% magnitude
of screening for GDM from a study in a similar setting
[11], 20% precision, 80% power, 5% non-response rate
and type I error of 5%. Each of the 2 study sites provided
half of the total sample. Convenient, consecutive sam-
pling was used to achieve the required sample.
The study population comprised of pregnant women
above 18 years of age, who had already received some
antenatal care and who were above the gestational age at
which screening for GDM is routinely performed. In-
cluded were pregnant women attending the antenatal
care specialist clinics, aged 18 years and above, posses-
sion of antenatal card, gestational age of 30 or more
weeks calculated using menstrual dates or earliest ultra
sound scan, and who attended a 1st or 2nd trimester
antenatal care visit at the study site. Women were ex-
cluded if they had pre-existing self-reported diagnosis of
diabetes mellitus, severe illness, mental illness, partici-
pated in another study or were taking corticosteroids,
antidepressants, diuretics or beta blockers.
Data collection
During the routine health talks all women were educated
about GDM and given details about the study. Informed,
written and signed consent was obtained from willing
participants. A mini check list confirmed eligibility of
participants.
Data collection tools were an interviewer-administered
questionnaire and data extraction sheet. Participants
were interviewed using a pre-tested, structured question-
naire in the language of choice between Kiswahili and
English. The questionnaire identified patient demo-
graphic characteristics, risk factors for GDM, socio-
economic factors associated with screening for GDM,
past obstetric and medical history and tests for glycemic
status and related information regarding screening for
GDM. Additional information including weight, height,
body mass index, blood pressure was obtained and veri-
fied from the antenatal cards, patient files and laboratory
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reports. This information was recorded on the data col-
lection sheet. Where information from the interview and
patient records differed, the latter were used.
Women were considered screened for GDM if WHO
2013 guidelines [3], Tanzania Diabetic association guide-
lines [10] or Tanzania ministry of health guidelines 2017
[9] had been followed. All participants found not to have
been screened for GDM were offered the 75 g OGTT.
The glucometer SD GlucoNavii® GDH blood glucose
monitoring system and SD BIOSENSOR INC lancets
were used. This apparatus had a coefficient of variation
5% above 5.55 mmol/l and within standard deviation 4
mg/dl for readings below 5.55 mmol/l. For those with
medical insurance, the cost of the test was covered by
the insurer. Cash paying clients were offered a dis-
counted price at the Aga Khan hospital and it was of-
fered free of charge for those who could not afford.
Interpretation of results was according to WHO 2013
guidelines [3]. Women diagnosed with GDM or pre-
diabetic states were informed and referred for appropri-
ate care.
Data were collected on possible determinants of
screening for GDM which were either socio-economic
factors or risk factors of GDM. The socio-economic fac-
tors included: education status/ literacy, marital status,
employment status, women’s autonomy, private health
insurance status, distance to hospital, journey time to
health facility, mode of transport, ability to pay for the
service/ financial status, husband support, family sup-
port, obstetric history, parity, awareness of GDM or its
risks, health care providers informing the women about
the test and help with household work.
The risk factors for GDM included: glycosuria, Body
Mass Index (BMI) > 25 at time of interview, hyperten-
sion in current pregnancy, history of chronic hyperten-
sion, history of pregnancy induced hypertension (PIH),
history of GDM, history of pre-diabetic states, family
history of hypertension, family history of diabetes melli-
tus, history of multiple pregnancy, history of delivering a
macrosomic (≥4 kg of weight) baby, clinical or ultra-
sound diagnosis of large for gestational age in the on-
going pregnancy, history of excessive weight gain (≥5 kg)
since 18 years of age, race, history of pregnancy loss and
grand-multiparity (≥ 5 pregnancies).
Data analysis
Data was entered into Microsoft excel 2007 and cleaned.
The data was then transferred to SPSS 20 for analysis.
We defined “magnitude” of screening for GDM as the
proportion of participants attending ANC who had re-
ceived any test aimed at screening for GDM. Various
tests done during screening were categorized and fre-
quencies and percentages for each calculated and re-
corded. The percentage of participants who had not
initially screened but were diagnosed with GDM by
OGTT in the study was the magnitude of undiagnosed
GDM. Socio-economic determinants of screening for
GDM and risk factors for GDM were evaluated for asso-
ciation with screening for GDM using the chi-square
test and associated p-values. Factors found to be statisti-
cally significant by chi square test were further analyzed
using logistic regression for possible association with
screening for GDM.
Results
The study period was July to September 2018. During
the study period July to September 2018, there were
2250 women who attended specialist ANC at the study
sites. As shown in Fig. 1, approximately 1500 were eli-
gible to participate. Women who consented were inter-
viewed. Six women were excluded. Two had overt
diabetes while four had participated in other studies.
Demographic and obstetric characteristics are summa-
rized in Table 1. The mean age of the participants was
30.2 years (SD: 4.8; range 20–44). Most of the partici-
pants were between 20 and 30 years, accounting for
57.6% of the study population. The mean gestational age
was 34.9 weeks of gestation (SD = 3.1; range 30–42). Of
all the participants, 97.2% were black African, while 2.8%
were of Asian or of other origins.
Magnitude of screening for GDM
The overall magnitude of screening for GDM at both
hospitals was 29.9% (107 of 358). The magnitude was
21.5% (38 of 177) at Aga Khan Hospital and 38.1% at
Muhimbili National Hospital (69 of 181). Of the 251 of
women found not to have been screened for GDM only
27% (68) accepted the offered OGTT.
Tests used to screen for GDM
Of the 107 participants screened for GDM, 56.8% (66)
had done random blood sugar (RBS), 32.8% (38) fasting
blood sugar (FBS), 6% [7] HbA1C and 3.4% [3] the 75 g
Oral glucose tolerance test (OGTT).
Prevalence of undiagnosed GDM
The prevalence of undiagnosed GDM was 27.9% (19 of 68).
Factors associated with screening for GDM
As shown in Tables 2 and 3, chi square analysis revealed
factors with statistically significant association with
screening for GDM to be: awareness about GDM
(p < 0.001), health worker communication about GDM
screening (p < 0.001), partner support during ANC (p =
0.045), family support during ANC (p 0.049), history of
pregnancy induced hypertension (PIH) (p = 0.022), his-
tory of delivering macrosomic baby (p = 0.023) and his-
tory of glycosuria (p = 0.002). Logistic regression analysis
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(Table 4) revealed that history of delivering a macroso-
mic baby (p = < 0.001 OR 2.15 95% CI: 1.12–4.10), his-
tory of PIH (p = < 0.021 OR 2.34 95% CI: 1.13–4.82) and
awareness of GDM (p = < 0.001 OR 2.79 95% CI: 1.74–
4.45) were the only 3 factors associated with screening
for GDM.
Discussion
In this study the magnitude of screening for GDM was
only 30%. This value is somewhat similar to a Cameroon
study which found the screening level at 22% [11]. Both
of these values are lower than the WHO target for a
screening strategy which is 70% of the target population
[16]. The study was done in specialist clinics in tertiary
facilities, with adequate facilities for screening. In this
study specialist clinics were considered because obstetri-
cians were expected to be able to address the complexity
and interpretation of different guidelines and tests for
GDM better than other cadres. The low screening rate
could not be attributed to poor resources or expertise.
Another study in the region showed that health workers
omit certain practices stipulated in ANC guidelines. In-
adequate screening was attributed to limited resources
and expertise in the rural settings in that study [7].
The tests used for screening for GDM in order of fre-
quency were RBS, FBS, HbA1C and OGTT. The trend
reflects the ease of performing a particular test. Com-
pared to the OGTT the other tests are easy to use, less
labour intensive and more accessible [17]. Random
blood sugar and HbA1C also do not require fasting [18].
Performing these tests is therefore convenient to both
the health worker and the pregnant woman [18].
Whereas the OGTT has better diagnostic accuracy than
the other tests, it is more expensive and laborious to
perform [18]. This possibly is the reason why it is per-
formed less frequently (3.4%) than other tests. If we were
to use the generally accepted OGTT as the screening
test for GDM, the magnitude of screening of 3.4% is far
below the expected standard of care. In Uganda the up-
take of the OGTT was shown to be 75.4% [5]. It would
therefore plausible for health workers to offer the OGTT
more in this setting.
The prevalence of undiagnosed GDM was 28%. Preva-
lence of GDM in a previous Tanzanian study also done
in an urban setting was 8.4% [19]. Just like in our study
the 75 g OGTT was used for diagnosis in that study.
Our findings may be suggestive of an increasing preva-
lence of GDM in Tanzanian urban areas. The prevalence
in our study is somewhat similar to 31.9% in Uganda [5],
Fig. 1 Study profile of participants attending Antenatal Care at Muhimbili National Hospital and Aga Khan Hospital Dar es Salaam in 2018
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31% in Cameroon [11] and 25.8% in south Africa [20].
These findings show a higher burden than the global
prevalence of 16% [21]. Uptake of the OGTT was 27%
which was similar to the 22% of the Cameroon study.
However the uptake varies from 75.4% found in a
Ugandan study [5] and 55.4% in a South African study
[20]. These higher uptake rates could be because in
Table 1 Baseline demographic and clinical characteristics of
participants attending Antenatal Care at Muhimbili National
Hospital and Aga Khan Hospital Dar es Salaam in 2018
Frequency
(Total 358)
Percentage
(Total 100%)
Age a
18–25 61 17.1
26–30 135 37.9
31–35 113 31.7
36–40 37 10.4
> 40 10 2.8
Residence
Ilala 95 26.5
Kinondoni 113 31.6
Ubungo 68 19.0
Temeke 42 11.7
Kigamboni 28 7.8
Outside Dar es salaam 12 3.4
Gravidity
Prime Gravida 94 26.3
G2 112 31.3
G3 82 22.9
G4 45 12.6
≥ G5 25 6.9
Number of GDM risk factors
0 2 0.6
1 20 5.6
2 66 18.4
3 114 31.8
4 79 22.1
≥ 5 77 21.5
Number of previous ANC visits
1 10 2.8
2 21 5.9
3 46 12.8
4 78 21.8
5 75 20.9
≥ 6 128 35.8
Gestational age
30–31.9 66 18.4
32–34.9 103 28.8
35–37.9 114 31.9
38–40.9 70 19.5
≥ 41 5 1.39
Key: ANC Antenatal Care, aData missing for 2 participants
Table 2 Univariable analysis of socio-economic determinants of
screening for Gestational Diabetes Mellitus among women
attending antenatal clinic at Muhimbili National Hospital and
Aga Khan Hospital Dar es Salaam in 2018
Factor Prevalence (%) p-value
Educated > tertiary level 71.8 0.926
Married 82.4 0.880
Independent source of income 79.6 0.270
Autonomy 76.0 0.331
Medical insurance 71.2 0.412
Personal vehicle 27.9 0.179
Live in Ilala 26.5 0.288
Having help with housework 82.7 0.886
Partner ANC attendance 64.8 0.045
Escorted by family member to ANC 52.8 0.049
Awareness of GDM 45.0 < 0.001
Health worker communication 27.7 < 0.001
Key: ANC Antenatal care, GDM Gestational Diabetes Mellitus
Table 3 Univariable analysis of risk factors for Gestational
Diabetes Mellitus among women attending Antenatal care at
Muhimbili National Hospital and Aga Khan Hospital Dar es
Salaam in 2018
Risk factor Prevalence (%) p-value
Grand multiparity 6.9 0.709
History of GDM 1.1 0.094
History of PIH 9.5 0.022
Hypertension detected in current pregnancy 2.5 0.707
Pre-diabetic state 2.0 0.325
Glycosuria 3.6 0.002
BMI > 25 88.5 0.619
History of big baby 12.6 0.023
LGA in current pregnancy 4.5 0.903
Excessive weight gain 65.9 0.281
Family history of DM 29.6 0.671
Family history of HT 43.6 0.123
History of multiple pregnancy 3.7 0.479
History of hypertension 4.5 0.662
History of pregnancy loss 27.9 0.587
Key: PIH Pregnancy Induced Hypertension, GDM Gestational Diabetes Mellitus,
ANC Antenatal care, HT Hypertension, LGA Large for Gestational Age, BMI Body
Mass Index
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these studies, the primary objective was to determine the
prevalence of GDM using the OGTT. In our study we
offered the OGTT as part of a secondary objective.
Factors found to be statistically significantly associ-
ated with screening were awareness about GDM, his-
tory of pregnancy induced hypertension (PIH) and
history of delivering a macrosomic baby. Awareness
of GDM in our study was 45%, which is similar to
40.3% in a multiethnic Australian study [22] but var-
ies from 17.5% in an Indian study [23]. Similar to the
findings in our study, another study in Tamil, India
showed that knowledge of GDM promotes GDM
screening [12]. People are more inclined to accept or
do tests if they are aware about the condition and its
complications. Health literacy enables patients to ac-
cess and effectively use health information [24], while
low health literacy is associated with poor health out-
comes [25]. PIH is a mild form of pre-eclampsia and
eclampsia which is the leading direct cause of mater-
nal death in Tanzania [26]. This could explain why
clinicians are more vigilant with these women. Deliv-
ering a macrosomic baby is the commonest complica-
tion of GDM in some settings. For example in a
Ugandan study, macrosomia was the only obstetric
complication associated with hyperglycemia in preg-
nancy [5]. This also explains the possible increased
vigilance with these women.
Conclusions
In conclusion, in this study we found a low magnitude
of screening for GDM (30%). This is inadequate com-
pared to the recommended WHO target of 70%. A sig-
nificant proportion (28%) of women with GDM had not
been diagnosed with the condition; which could account
for significant adverse pregnancy outcomes.
A majority of participants (over 75%) had attended
ANC 4 or more times by the time we evaluated them
for screening. Those many contacts with a health
worker are a missed opportunity to screen for GDM
and to provide quality, comprehensive ANC services.
A sizeable proportion of women were not aware of
GDM. This calls for wider sensitization on GDM.
Universal rather than selective screening for GDM
should be adopted in this setting given the high
prevalence of risk factors for GDM. A less cumber-
some gold standard test for GDM diagnosis and
Table 4 Multivariate analysis of factors associated with screening for Gestational Diabetes Mellitus among ANC attendees at
Muhimbili National Hospital and Aga Khan Hospital Dar es Salaam in 2018
Characteristic Screened for GDM Odds ratio (95% CI) p-value
Yes = 107 (N/%) No = 251 (N/%)
Glycosuria
Yes 9 (8.4%) 4 (1.6%) 0.96 (0.880–1.053) 0.401
No 97 (90.7%) 247 (98.4%)
History of delivering big baby
Yes 20 (18.7%) 25 (10%) 2.15 (1.127–4.101) 0.020
No 87 (81.3%) 226 (90%)
History of PIH
Yes 16 (15%) 18 (7.2%) 2.34 (1.131–4.827) 0.021
No 91 (85%) 233 (92.8%)
Awareness of GDM
Yes 67 (62.6%) 94 (37.5%) 2.79 (1.749–4.459) < 0.001
No 40 (37.4%) 157 (62.5%)
Partner attendance of ANC
Yes 77 (72%) 155 (61.8%) 0.96 (0.902–1.038) 0.360
No 29 (27.1%) 96 (38.2%)
Family member attendance of ANC
Yes 65 (60.7%) 124 (49.4%) 1.57 (0.993–2.504) 0.053
No 42 (39.3%) 127 (50.6%)
Health worker communication about GDM tests
Yes 91 (85%) 8 (3.2%) 1.03 (0.996–1.068) 0.087
No 15 (14%) 219 (87.3%)
Key: PIH Pregnancy Induced Hypertension, GDM Gestational Diabetes Mellitus, ANC Antenatal care
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screening needs to be developed to facilitate ease of
screening. A study of attitudes and practices of ANC
providers would dissect further why adequate screen-
ing for GDM is not conducted. Studies should be
done to determine factors associated with poor uptake
of the OGTT in this setting. Follow up studies should
be done on interventions to increase screening for
GDM.
Generalizability
This study was hospital based and urban based. There-
fore the study findings may not be generalised to all
settings.
Limitations
In our study, patients were consecutively sampled. This
method of sampling could have introduced some level of
bias in our findings. However, we have no reasons to be-
lieve that manner of selecting our sample would be asso-
ciated with the dependent variable of being screened or
not. The principal investigator and the research assis-
tants were not part of the clinical teams offering ANC
services.
Observational studies, like ours are prone to social de-
sirability phenomenon while getting responses from
study participants. However, the impact of this
phenomenon on our study was reduced for most of the
time by corroborating the participants’ responses with
data that was written on the ANC. Our study did not ex-
plore the specific laboratory methods of performing the
tests used in GDM screening. However, this could not
have affected the study results.
Our study did not explore effects of health worker
workload, knowledge and cost of test on the magnitude
of screening for GDM. However, cost for the tests was
either covered by insurance, heavily discounted or of-
fered free of charge by the health services. All ANC was
offered by obstetricians who are assumed to have ad-
equate knowledge and similar level of training. We have
no reason to believe that the study results could be dif-
ferent if these factors were explored.
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